These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8513459)

  • 1. Controlling the costs of antibiotic resistance.
    North D
    Clin Ther; 1993; 15 Suppl A():3-11. PubMed ID: 8513459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic cost control measures in a hospital pharmacy.
    Manzo J; Amodio-Groton MA; Kleinmann K
    Clin Ther; 1993; 15 Suppl A():37-43. PubMed ID: 8513460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
    Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
    Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic restriction in hospitals associated with medical schools.
    Klapp DL; Ramphal R
    Am J Hosp Pharm; 1983 Nov; 40(11):1957-60. PubMed ID: 6650526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals.
    MacKenzie FM; Gould IM; Bruce J; Mollison J; Monnet DL; Krcmery V; Cookson B; van der Meer JW
    J Hosp Infect; 2007 Jun; 65 Suppl 2():73-81. PubMed ID: 17540246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements.
    Thrasher CM; Stefl ME; Dorner FH
    Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods of controlling cephalosporin use in Canadian hospitals.
    Godin JP; Sketris IS; Merrett RA; Marrie TJ
    Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determining the formulary status of quinolone antibiotics: one institution's approach.
    Nightingale CH; Lubowski T; On A; Quintiliani R
    Hosp Formul; 1992 May; 27(5):509-10, 513-4, 516. PubMed ID: 10128710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
    Green JA; Chawla AK; Fong PA
    Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
    Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
    Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling financial variables--changing prescribing patterns.
    Abramowitz PW
    Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial formulary management: meeting the challenge in a health maintenance organization.
    Carlson JA
    Pharmacotherapy; 1991; 11(1 ( Pt 2)):32S-35S. PubMed ID: 2011571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assuring rational antibiotic use: the impact of a joint microbiology-pharmacy surveillance program.
    Plumridge RJ; McGechie DB
    Aust Health Rev; 1984; 7(4):269-77. PubMed ID: 10269945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-assisted concurrent antibiotic review in a community hospital.
    Scarafile PD; Campbell BD; Kilroy JE; Mathewson HO
    Am J Hosp Pharm; 1985 Feb; 42(2):313-5. PubMed ID: 3838416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of managerial intervention on drug utilization pattern at King Chulalongkorn Memorial Hospital.
    Limpanasithikul W; Wangsaturaka D; Nantawan P; Itthipanichapong C; Thamaree S; Wittayalertpanya S; Ketcharoen A; Taworn N; Kemsri W; Kusolsomboon T; Tangphao O
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S336-43. PubMed ID: 12188432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of antibiotic-resistant bacteria: memorandum from a WHO meeting. World Health Organization Scientific Working Group on Antimicrobial Resistance.
    Am J Hosp Pharm; 1984 Jul; 41(7):1329-37. PubMed ID: 6540519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy.
    Pinto Pereira LM; Phillips M; Ramlal H; Teemul K; Prabhakar P
    BMC Infect Dis; 2004 Dec; 4(1):59. PubMed ID: 15601475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.